Trichosanthin suppresses the proliferation of glioma cells by inhibiting LGR5 expression and the Wnt/β-catenin signaling pathway

Miao,Junjie; Jiang,Yilin; Wang,Dongliang; Zhou,Jingru; Fan,Cungang; Jiao,Feng; Liu,Bo; Zhang,Jun; Wang,Yangshuo; Zhang,Qingjun

doi:10.3892/or.2015.4290

Trichosanthin suppresses the proliferation of glioma cells by inhibiting LGR5 expression and the Wnt/β-catenin signaling pathway

Authors:
- Junjie Miao
- Yilin Jiang
- Dongliang Wang
- Jingru Zhou
- Cungang Fan
- Feng Jiao
- Bo Liu
- Jun Zhang
- Yangshuo Wang
- Qingjun Zhang
View Affiliations

Affiliations: Department of Neurosurgery, Peking University People's Hospital, Beijing 100044, P.R. China
Published online on: September 18, 2015 https://doi.org/10.3892/or.2015.4290
Pages: 2845-2852
Copyright: © Miao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Studies have indicated that trichosanthin (TCS), a bioactive protein extracted and purified from the tuberous root of Trichosanthes kirilowii (a well‑known traditional Chinese medicinal plant), produces antitumor effects on various types of cancer cells. However, the effects of TCS on glioma cells are poorly understood. The objective of this study was to investigate the antitumor effects of TCS on the U87 and U251 cell lines. The in vitro effects of TCS on these two cell lines were determined using a Cell Counting Kit‑8 (CCK‑8) assay, Annexin V‑FITC staining, DAPI staining, Transwell assays, terminal deoxynucleotidyl transferase‑mediated dUTP nick end‑labeling (TUNEL) assays, 5,5',6,6'‑tetrachloro‑1,1',3,3'‑tetraethyl‑imidacarbocyanine iodide (JC‑1) staining and western blotting, which was utilized to assess the expression of leucine‑rich repeat‑containing G protein‑coupled receptor 5 (LGR5) and key proteins in the Wnt/β‑catenin signaling pathway. Our data indicated that TCS inhibited the proliferation of glioma cells in a dose‑ and time‑dependent manner and played a role in inhibiting glioma cell invasion and migration. Additional investigation revealed that the expression levels of LGR5 and of key proteins in the Wnt/β‑catenin signaling pathway were markedly decreased after TCS treatment. The results suggest that TCS may induce apoptosis in glioma cells by targeting LGR5 and repressing the Wnt/β‑catenin signaling pathway. In the future, in vivo experiments should be conducted to examine the potential use of this compound as a novel therapeutic agent for gliomas.

View Figures

View References

1	Jansen M, Yip S and Louis DN: Molecular pathology in adult gliomas: Diagnostic, prognostic, and predictive markers. Lancet Neurol. 9:717–726. 2010. View Article : Google Scholar : PubMed/NCBI
2	Wen PY and Kesari S: Malignant gliomas in adults. N Engl J Med. 359:492–507. 2008. View Article : Google Scholar : PubMed/NCBI
3	Fortin Ensign SP, Mathews IT, Symons MH, Berens ME and Tran NL: Implications of Rho GTPase signaling in glioma cell invasion and tumor progression. Front Oncol. 3:2412013. View Article : Google Scholar : PubMed/NCBI
4	Maraganore JM, Joseph M and Bailey MC: Purification and characterization of trichosanthin. Homology to the ricin A chain and implications as to mechanism of abortifacient activity. J Biol Chem. 262:11628–11633. 1987.PubMed/NCBI
5	Zhang XJ and Wang JH: Homology of trichosanthin and ricin A chain. Nature. 321:477–478. 1986. View Article : Google Scholar : PubMed/NCBI
6	Sha O, Niu J, Ng TB, Cho EY, Fu X and Jiang W: Antitumor action of trichosanthin, a type 1 ribosome-inactivating protein, employed in traditional Chinese medicine: A mini review. Cancer Chemother Pharmacol. 71:1387–1393. 2013. View Article : Google Scholar : PubMed/NCBI
7	Zhang CY, Gong YX, Ma H, An CC and Chen DY: Trichosanthin induced calcium-dependent generation of reactive oxygen species in human choriocarcinoma cells. Analyst. 125:1539–1542. 2000. View Article : Google Scholar : PubMed/NCBI
8	Zhang C, Gong Y, Ma H, An C, Chen D and Chen ZL: Reactive oxygen species involved in trichosanthin-induced apoptosis of human choriocarcinoma cells. Biochem J. 355:653–661. 2001. View Article : Google Scholar : PubMed/NCBI
9	Wang P, Chen LL, Yan H and Li JC: Trichosanthin suppresses HeLa cell proliferation through inhibition of the PKC/MAPK signaling pathway. Cell Biol Toxicol. 25:479–488. 2009. View Article : Google Scholar
10	Wang P, Xu S, Zhao K, Xiao B and Guo J: Increase in cytosolic calcium maintains plasma membrane integrity through the formation of microtubule ring structure in apoptotic cervical cancer cells induced by trichosanthin. Cell Biol Int. 33:1149–1154. 2009. View Article : Google Scholar : PubMed/NCBI
11	Cui L, Song J, Wu L, Huang L, Wang Y, Huang Y, Yu H, Huang Y, You CC and Ye J: Smac is another pathway in the anti-tumour activity of trichosanthin and reverses trichosanthin resistance in CaSki cervical cancer cells. Biomed Pharmacother. 69:119–124. 2015. View Article : Google Scholar : PubMed/NCBI
12	Dou CM and Li JC: Effect of extracts of trichosanthes root tubers on HepA-H cells and HeLa cells. World J Gastroenterol. 10:2091–2094. 2004. View Article : Google Scholar : PubMed/NCBI
13	Fang EF, Zhang CZ, Zhang L, Wong JH, Chan YS, Pan WL, Dan XL, Yin CM, Cho CH and Ng TB: Trichosanthin inhibits breast cancer cell proliferation in both cell lines and nude mice by promotion of apoptosis. PLoS One. 7:e415922012. View Article : Google Scholar : PubMed/NCBI
14	Zheng YT, Zhang WF, Ben KL and Wang JH: In vitro immuno-toxicity and cytotoxicity of trichosanthin against human normal immunocytes and leukemia-lymphoma cells. Immunopharmacol Immunotoxicol. 17:69–79. 1995. View Article : Google Scholar : PubMed/NCBI
15	Li J, Xia X, Ke Y, Nie H, Smith MA and Zhu X: Trichosanthin induced apoptosis in HL-60 cells via mitochondrial and endoplasmic reticulum stress signaling pathways. Biochim Biophys Acta. 1770:1169–1180. 2007. View Article : Google Scholar : PubMed/NCBI
16	Li J, Xia X, Nie H, Smith MA and Zhu X: PKC inhibition is involved in trichosanthin-induced apoptosis in human chronic myeloid leukemia cell line K562. Biochim Biophys Acta. 1770:63–70. 2007. View Article : Google Scholar
17	Byers VS, Levin AS, Malvino A, Waites L, Robins RA and Baldwin RW: A phase II study of effect of addition of trichosanthin to zidovudine in patients with HIV disease and failing antiretroviral agents. AIDS Res Hum Retroviruses. 10:413–420. 1994. View Article : Google Scholar : PubMed/NCBI
18	McGrath MS, Hwang KM, Caldwell SE, Gaston I, Luk KC, Wu P, Ng VL, Crowe S, Daniels J and Marsh J: GLQ223: An inhibitor of human immunodeficiency virus replication in acutely and chronically infected cells of lymphocyte and mononuclear phagocyte lineage. Proc Natl Acad Sci USA. 86:2844–2848. 1989. View Article : Google Scholar : PubMed/NCBI
19	Yang N, Li Z, Jiao Z, Gu P, Zhou Y, Lu L and Chou KY: A Trichosanthin-derived peptide suppresses type 1 immune responses by TLR2-dependent activation of CD8(+)CD28(−) Tregs. Clin Immunol. 153:277–287. 2014. View Article : Google Scholar : PubMed/NCBI
20	Tang NL, Chan WL, Ke YO, Mak MK, Lai FM and Tam SC: Acute renal failure and proximal tubule lesions after trichosanthin injection in rats. Exp Mol Pathol. 64:78–89. 1997. View Article : Google Scholar : PubMed/NCBI
21	Li F, Mei Y, Wang Y, Chen C, Tu J, Xiao B and Xu L: Trichosanthin inhibits antigen-specific T cell expansion through nitric oxide-mediated apoptosis pathway. Cell Immunol. 234:23–30. 2005. View Article : Google Scholar : PubMed/NCBI
22	Ng TB, Liu WK, Tsao SW and Yeung HW: Effect of trichosanthin and momorcharins on isolated rat hepatocytes. J Ethnopharmacol. 3:81–87. 1994. View Article : Google Scholar
23	Garcia PA, Bredesen DE, Vinters HV, Graefin von Einsiedel R, Williams RL, Kahn JO, Byers VS, Levin AS, Waites LA and Messing RO: Neurological reactions in HIV-infected patients treated with trichosanthin. Neuropathol Appl Neurobiol. 19:402–405. 1993. View Article : Google Scholar : PubMed/NCBI
24	Ng TB, Kwong WH and Yeung HW: Intravenous injections of the ribosome inactivating protein trichosanthin did not affect methionine enkephalin and β-endorphin levels in the mouse brain and pituitary. Biochem Mol Biol Int. 39:985–989. 1996.PubMed/NCBI
25	Rot S, Taubert H, Bache M, Greither T, Würl P, Eckert AW, Schubert J, Vordermark D and Kappler M: A novel splice variant of the stem cell marker LGR5/GPR49 is correlated with the risk of tumor-related death in soft-tissue sarcoma patients. BMC Cancer. 11:4292011. View Article : Google Scholar : PubMed/NCBI
26	Stewart LA: Chemotherapy in adult high-grade glioma: A systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet. 359:1011–1018. 2002. View Article : Google Scholar : PubMed/NCBI
27	Bleehen NM and Stenning SP: The Medical Research Council Brain Tumour Working Party: A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. Br J Cancer. 64:769–774. 1991. View Article : Google Scholar : PubMed/NCBI
28	Hsu SY, Liang SG and Hsueh AJ: Characterization of two LGR genes homologous to gonadotropin and thyrotropin receptors with extracellular leucine-rich repeats and a G protein-coupled, seven-transmembrane region. Mol Endocrinol. 12:1830–1845. 1998. View Article : Google Scholar : PubMed/NCBI
29	Hsu SY, Kudo M, Chen T, Nakabayashi K, Bhalla A, van der Spek PJ, van Duin M and Hsueh AJ: The three subfamilies of leucine-rich repeat-containing G protein-coupled receptors (LGR): Identification of LGR6 and LGR7 and the signaling mechanism for LGR7. Mol Endocrinol. 14:1257–1271. 2000. View Article : Google Scholar : PubMed/NCBI
30	Barker N and Clevers H: Leucine-rich repeat-containing G-protein-coupled receptors as markers of adult stem cells. Gastroenterology. 138:1681–1696. 2010. View Article : Google Scholar : PubMed/NCBI
31	McClanahan T, Koseoglu S, Smith K, Grein J, Gustafson E, Black S, Kirschmeier P and Samatar AA: Identification of overexpression of orphan G protein-coupled receptor GPR49 in human colon and ovarian primary tumors. Cancer Biol Ther. 5:419–426. 2006. View Article : Google Scholar : PubMed/NCBI
32	Scannell CA, Pedersen EA, Mosher JT, Krook MA, Nicholls LA, Wilky BA, Loeb DM and Lawlor ER: LGR5 is expressed by Ewing sarcoma and potentiates Wnt/beta-catenin signaling. Front Oncol. 3:812013. View Article : Google Scholar
33	Nakata S, Campos B, Bageritz J, Bermejo JL, Becker N, Engel F, Acker T, Momma S, Herold-Mende C, Lichter P, et al: LGR5 is a marker of poor prognosis in glioblastoma and is required for survival of brain cancer stem-like cells. Brain Pathol. 23:60–72. 2013. View Article : Google Scholar
34	Wang D, Zhou J, Fan C, Jiao F, Liu B, Sun P, Miao J and Zhang Q: Knockdown of LGR5 suppresses the proliferation of glioma cells in vitro and in vivo. Oncol Rep. 31:41–49. 2014.
35	Wend P, Holland JD, Ziebold U and Birchmeier W: Wnt signaling in stem and cancer stem cells. Semin Cell Dev Biol. 21:855–863. 2010. View Article : Google Scholar : PubMed/NCBI
36	Glinka A, Dolde C, Kirsch N, Huang YL, Kazanskaya O, Ingelfinger D, Boutros M, Cruciat CM and Niehrs C: LGR4 and LGR5 are R-spondin receptors mediating Wnt/β-catenin and Wnt/PCP signalling. EMBO Rep. 12:1055–1061. 2011. View Article : Google Scholar : PubMed/NCBI
37	Anna CH, Iida M, Sills RC and Devereux TR: Expression of potential beta-catenin targets, cyclin D1, c-Jun, c-Myc, E-cadherin, and EGFR in chemically induced hepatocellular neoplasms from B6C3F1 mice. Toxicol Appl Pharmacol. 190:135–145. 2003. View Article : Google Scholar : PubMed/NCBI
38	Hsu HC, Liu YS, Tseng KC, Tan BC, Chen SJ and Chen HC: LGR5 regulates survival through mitochondria-mediated apoptosis and by targeting the Wnt/β-catenin signaling pathway in colorectal cancer cells. Cell Signal. 26:2333–2342. 2014. View Article : Google Scholar : PubMed/NCBI